序号 |
标题 |
次数 |
作者 |
发布时间 |
78391 |
VG-PEG24-Chol 24单位PEG接头偶联胆固醇多肽 |
153 |
zyl |
2024-12-18 |
78392 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭环辛烯衍生物二苄基环辛烯 |
100 |
h |
2024-12-18 |
78393 |
CAS: 330970-70-2 Alloc-Val-Ala-OH,N-Alloc-L-valyl-L-alanine 或 (S)-2-((S)-2-(Allyloxycarbonylamino)-3-methylbutanamido)propanoic acid |
85 |
WYQ |
2024-12-18 |
78394 |
3-[(2-氨基乙基)二硫]丙酸,Aminoethyl-SS-propionic acid,ADC定制 |
123 |
wyh |
2024-12-18 |
78395 |
负载槲皮素与多柔比星的脂质体,QUE-DOX--Lips,靶向脂质体定制服务 |
158 |
axc |
2024-12-18 |
78396 |
DOTA-siRNA 螯合剂DOTA偶联siRNA纳米颗粒 |
135 |
h |
2024-12-18 |
78397 |
cFLFLFK-PEG12-Cy3的介绍 |
103 |
zyl |
2024-12-18 |
78398 |
DOTA-E{PEG4-E[Gly3-c(RGDfK)]2}2 |
124 |
h |
2024-12-18 |
78399 |
RGD修饰的共载姜黄素和阿霉素脂质体,cRGD-(C+D/LP),提供荧光脂质体定制服务 |
111 |
axc |
2024-12-18 |
78400 |
螯合剂DOTA-NHS |
107 |
h |
2024-12-18 |
78401 |
Mal-PEG2-Val-Ala-PAB-PNP,马来酰亚胺-二聚乙二醇-VAL-ALA-PAB-PNP 酯 |
115 |
kx |
2024-12-18 |
78402 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)螯合物偶联配体[SHALs]) |
118 |
h |
2024-12-18 |
78403 |
DOTA(Gd))-b-PCL DOTA(Gd)螯合物修饰聚己内酯聚合物胶束 |
98 |
h |
2024-12-18 |
78404 |
土贝母苷甲脂质体,Tub,I-LPs,载药脂质体定制服务 |
91 |
axc |
2024-12-18 |
78405 |
半乳糖-RGD2 Galacto-RGD2 |
119 |
h |
2024-12-18 |
78406 |
DOTA-dPEG2-R954 DOTA偶联B1R拮抗剂R954 |
94 |
h |
2024-12-18 |
78407 |
竹节参皂苷Ⅳa脑靶向脂质体,脂质体纳米载体定制服务 |
137 |
axc |
2024-12-18 |
78408 |
cas:253863-34-2,Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP,ADC定制 |
93 |
wyh |
2024-12-18 |
78409 |
CAS: 1343407-91-9 Alloc-Val-Ala-PAB(或Val-Ala-PAB-OH) |
103 |
WYQ |
2024-12-18 |
78410 |
DOTA-PEG-NH2 DOTA-聚乙二醇-氨基 |
113 |
h |
2024-12-18 |
78411 |
R-8PEG-4PCL的介绍 |
100 |
zyl |
2024-12-18 |
78412 |
N3-tri-EG-OPFP,ADC定制 |
85 |
wyh |
2024-12-18 |
78413 |
cas:1949793-41-2, Mal-amido-PEG4-Val-Cit-PAB-OH,马来酰亚胺-四聚乙二醇-VAL-CIT-PAB |
94 |
kx |
2024-12-18 |
78414 |
甘露糖修饰脂质体包装ASFV,CP204L基因,多功能载药脂质体定制服务 |
106 |
axc |
2024-12-18 |
78415 |
DOTA-βA-NH2 |
100 |
h |
2024-12-18 |
78416 |
Py-ds-dmBut-OPFP,2101206-44-2,ADC定制 |
96 |
wyh |
2024-12-18 |
78417 |
ALD-di-EG-OPFP,ADC定制 |
85 |
wyh |
2024-12-18 |
78418 |
cas:2055047-18-0,Azido-PEG3-Val-Cit-PAB-PNP,叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
76 |
kx |
2024-12-18 |
78419 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
129 |
axc |
2024-12-18 |
78420 |
cas:159857-79-1,Val-cit-PAB-OH,ADC定制 |
101 |
wyh |
2024-12-18 |
78421 |
双载IR780与HCQ的温敏脂质体(IR780/HCQ-Lip) |
130 |
axc |
2024-12-18 |
78422 |
endo BCN-PEG3-Val-Cit,(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
86 |
kx |
2024-12-18 |
78423 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
96 |
h |
2024-12-18 |
78424 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
115 |
axc |
2024-12-18 |
78425 |
cas:2226472-28-0 ,DBCO-PEG4-Val-Cit-PAB-PNP,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
89 |
kx |
2024-12-18 |
78426 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
79 |
h |
2024-12-18 |
78427 |
OA-PEG5烷基链定制 |
124 |
zyl |
2024-12-18 |
78428 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
118 |
axc |
2024-12-18 |
78429 |
DOTA-PEG27-Cys-VS |
86 |
h |
2024-12-18 |
78430 |
cas:1613321-01-9 ,6-Azidohexanoyl-Val-Cit-PAB,6-叠氮己酰-VAL-CIT-PAB |
82 |
kx |
2024-12-18 |
78431 |
MPA-PEG4-GB-6的功能与应用 |
135 |
zyl |
2024-12-18 |
78432 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
79 |
h |
2024-12-18 |
78433 |
负载吡非尼酮的肺靶向纳米脂质体,GALA-PFD-Lip,多功能载药脂质体定制服务 |
146 |
axc |
2024-12-18 |
78434 |
PAMAM-PG-g-s-s-DOTA(Gd)+FA 纳米球状MRI造影剂 |
115 |
h |
2024-12-18 |
78435 |
DBCO-Val-Cit-PAB-MMAE,二苯并环辛炔-VAL-CIT-PAB-MMAE |
75 |
kx |
2024-12-18 |